Eptacog-α/factor-VIII-inhibitor-bypassing-fractionLack of efficacy and blood coagulation: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2019年 / 1778卷 / 1期

关键词：

D O I：

10.1007/s40278-019-70999-y

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：196 / 196

相关论文

共 50 条

[1] Eptacog-alfa/factor-VIII-inhibitor-bypassing-fractionLack of efficacy: case report
Reactions Weekly, 2021, 1863 (1) : 146 - 146
[2] Factor-VIII-inhibitor-bypassing-fractionLack of efficacy
Reactions Weekly, 2024, 1999 (1) : 175 - 175
[3] Eptacog-α/factor VIII inhibitor bypassing fraction interactionFatal intracardiac thrombosis: case report
Reactions Weekly, 2010, 1311 (1) : 23 - 23
[4] Eptacog-α/factor-VIII-inhibitor bypassing fractionThrombotic ischaemic cerebral infarction: case report
Reactions Weekly, 2018, 1725 (1) : 143 - 143
[5] Eptacog-α/factor-VIII-inhibitor-bypassing-fraction/rituximabVarious toxicities: 6 case reports
Reactions Weekly, 2020, 1786 (1) : 79 - 79
[6] Eptacog alfa/factor VIII inhibitor bypassing fractionVarious toxicities: case report
Reactions Weekly, 2017, 1669 (1) : 124 - 124
[7] Eptacog-α/factor VIII inhibitor bypassing fractionHypersensitivity and elevated D-dimer levels: 4 case reports
Reactions Weekly, 2011, 1365 (1) : 19 - 19
[8] Eptacog α/factor VIII inhibitor bypassing fraction/factor VII stimulantsAnaphylaxis and disseminated intravascular coagulation in an elderly patient: case report
Reactions Weekly, 2009, 1262 (1) : 13 - 13
[9] Eptacog-αDevelopment of factor-VII inhibitor: case report
Reactions Weekly, 2023, 1947 (1) : 176 - 176
[10] Emicizumab/eptacog-α/factor-VIII-inhibitor-bypassing-fractionVenous thromboembolism, ST-segment elevation myocardial infarction and pulmonary embolism: case report
Reactions Weekly, 2020, 1799 (1) : 165 - 165

← 1 2 3 4 5 →